Vietnam Hemodialysis Equipment Market Report 2023 to 2030

Vietnam Hemodialysis Equipment Market Analysis

$ 3999

The Vietnam Hemodialysis Equipment Market was valued at $70.6 Mn in 2023 and is projected to grow at a CAGR of 7.83% from 2023 to 2023, to $119.7 Mn by 2030. The key drivers of this industry are increasing incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), availability of advanced dialysis machines and consumables, government initiatives to improve dialysis accessibility, growing adoption of home haemodialysis, expansion of dialysis service providers which has contributed to market growth. The industry is primarily dominated by players such as Baxter, B. Braun SE, Fresenius Medical Care AG, Medtronic among others.

ID: IN10VNMD018 CATEGORY: Medical Devices GEOGRAPHY: Vietnam AUTHOR: Mahima Reddy

Buy Now

Vietnam Hemodialysis Equipment Market Executive Summary

The Vietnam Hemodialysis Equipment Market is at around $70.6 Mn in 2023 and is projected to reach $119.7 Mn in 2030, exhibiting a CAGR of 7.83% during the forecast period 2023-2030.

Hemodialysis is a vital treatment for individuals suffering from end-stage renal disease, utilizing advanced medical equipment to perform its critical function. The hemodialysis machine, a complex apparatus, comprises several key components working in concert. These include, dialyzer, often referred to as an artificial kidney, which filters the blood, blood pump that circulates the patient's blood through the system, dialysate pump that manages the flow of the dialysis solution, an air detector to prevent air embolisms, a heparin pump for anticoagulation management, temperature and conductivity monitor to maintain proper electrolyte balance in the dialysate.

Each of these components plays a crucial role in ensuring the safe and effective cleansing of the patient's blood, mimicking the function of healthy kidneys. This sophisticated system allows patients with kidney failure to maintain their health and quality of life by removing waste products and excess fluids from their blood.

Side effects can include low blood pressure, muscle cramps, and fatigue. Dietary restrictions and medication management are often necessary alongside dialysis treatment. While hemodialysis is not a cure for kidney failure, it effectively manages the condition, allowing many patients to lead active lives. It's often used as a long-term treatment or as a bridge to kidney transplantation. Ongoing research aims to improve dialysis technology and patient outcomes.

In Vietnam, the burden of chronic kidney disease remains high, with over 10,000 cases per 100,000 and 20.6 deaths per 100,000. The incidence of chronic kidney disease was estimated to be approximately 120 per 1 Mn people in Vietnam. The hemodialysis market is driven by significant factors like aging population, increase prevalence rate of chronic diseases, increasing incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), availability of advanced dialysis machines and consumables, government initiatives to improve dialysis accessibility, growing adoption of home haemodialysis, expansion of dialysis service providers which has contributed to market growth.

Some of the major players operating in the Vietnam Hemodialysis Equipment Market are Baxter, B. Braun SE, Fresenius Medical Care AG, Medtronic, Asahi Kasei Medical Co., Ltd, Nipro Corp, DaVita, Quanta Dialysis Technologies, among others.

Vietnam Hemodialysis Equipment Market Report 2023 to 2030

Market Dynamics

Market Drivers

Increasing Prevalence of Chronic Kidney Disease and ESRD: Vietnam has seen a rise in the number of people living with chronic kidney disease (CKD) and end-stage renal disease (ESRD), In Vietnam, the burden of chronic kidney disease remains high, with over 10,000 cases per 100,000 and 20.6 deaths per 100,000. The incidence of chronic kidney disease was estimated to be approximately 120 per 1 Mn people in Vietnam, which is the key driver of hemodialysis market in Vietnam.

Growing Adoption of Home Dialysis and Portable Devices: There is a trend towards increased use of home dialysis and portable/wearable dialysis technologies in Vietnam. These innovations improve patient quality of life by allowing more flexibility and independence in managing their condition.

Aging Population and Chronic Conditions: Vietnam's aging population has contributed to a rise in chronic diseases like diabetes and hypertension, which are major risk factors for CKD and ESRD. This has increased the patient pool requiring dialysis treatments, driving demand for hemodialysis devices.

Market Restraints

High Cost of Dialysis Equipment and Consumables: The high cost of dialysis machines, as well as ongoing consumables and supplies, can limit access for some patients, especially those without comprehensive healthcare coverage. Ultimately hindering the market growth rate.

Shortage of Skilled Healthcare Professionals: There is a shortage of healthcare professionals, such as nurses and technicians, who are trained in operating and maintaining dialysis devices. This can create challenges in ensuring proper use and maintenance of the equipment. Thus, hampering the market growth rate.

Regulatory Hurdles and Approval Processes: The regulatory environment in Vietnam can pose challenges, with lengthy approval processes for new dialysis technologies. This can slow down the introduction of innovative devices to the market. Limiting the market growth rate.

Regulatory Landscape and Reimbursement Scenario

Vietnam's medical device regulatory system is overseen by the Department of Medical Equipment and Construction (DMEC) under the Ministry of Health. The country has been working to modernize its regulatory framework, with the key legislation being Decree 98/2021/ND-CP, which came into effect in 2022. This decree categorizes medical devices into four risk-based classes: A (low risk), B, C, and D (highest risk), with hemodialysis equipment typically falling into higher risk categories. All medical devices must be registered before being marketed in Vietnam, with requirements varying based on the device classification. The registration process involves submitting technical documentation, quality management system certificates, and clinical evidence for higher-risk devices. Local representation is required for foreign manufacturers.

Vietnam operates a mixed healthcare system. The primary public health insurance program, Vietnam Social Security (VSS), provides some coverage for hemodialysis treatments. The coverage rate for dialysis under VSS is typically around 80-100% of the cost, depending on the patient's insurance category and the healthcare facility level.

Competitive Landscape

Key Players

Here are some of the major key players in the Vietnam Hemodialysis Equipment Market:

Nikkiso Co., Ltd.
Asahi Kasei Medical
Medtronic
Fresenius Medical Care
Baxter International
B. Braun
Nipro Corporation
Diaverum
DaVita Inc.
Quanta Dialysis Technologies

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Vietnam Hemodialysis Equipment Market Segmentation

By Hemodialysis Type

Conventional Hemodialysis
Short Daily Hemodialysis
Nocturnal Hemodialysis

By Product & Services

Equipment
Consumables
Dialysis Drugs
Services

By End Use

Home-based
Hospital-based

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.